GR3007541T3 - - Google Patents
Info
- Publication number
- GR3007541T3 GR3007541T3 GR930400557T GR930400557T GR3007541T3 GR 3007541 T3 GR3007541 T3 GR 3007541T3 GR 930400557 T GR930400557 T GR 930400557T GR 930400557 T GR930400557 T GR 930400557T GR 3007541 T3 GR3007541 T3 GR 3007541T3
- Authority
- GR
- Greece
- Prior art keywords
- factor viii
- factor
- phosphatidylserine
- phosphatidylethanolamine
- phosphatidylcholine
- Prior art date
Links
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 abstract 3
- 108010054218 Factor VIII Proteins 0.000 abstract 3
- 102000001690 Factor VIII Human genes 0.000 abstract 3
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 abstract 3
- 229960000301 factor viii Drugs 0.000 abstract 3
- 150000003904 phospholipids Chemical class 0.000 abstract 3
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 abstract 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 2
- 150000008104 phosphatidylethanolamines Chemical class 0.000 abstract 2
- 238000001261 affinity purification Methods 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 108010047303 von Willebrand Factor Proteins 0.000 abstract 1
- 102100036537 von Willebrand factor Human genes 0.000 abstract 1
- 229960001134 von willebrand factor Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/074,123 US4795806A (en) | 1987-07-16 | 1987-07-16 | Phospholipid affinity purification of Factor VIII:C |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3007541T3 true GR3007541T3 (el) | 1993-08-31 |
Family
ID=22117866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR930400557T GR3007541T3 (el) | 1987-07-16 | 1993-04-01 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4795806A (el) |
| EP (1) | EP0303064B1 (el) |
| AT (1) | ATE87632T1 (el) |
| DE (1) | DE3879803T2 (el) |
| ES (1) | ES2053631T3 (el) |
| GR (1) | GR3007541T3 (el) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5930890A (en) * | 1989-06-20 | 1991-01-08 | Scripps Clinic And Research Foundation | The phospholipid binding domain of factor viii |
| US5110907A (en) * | 1989-08-01 | 1992-05-05 | Alpha Therapeutic Corporation | Factor viii complex purification using heparin affinity chromatography |
| WO1995003332A1 (en) * | 1993-07-23 | 1995-02-02 | Baxter International Inc. | Activated human factor viii and method of preparation |
| US5576291A (en) * | 1993-09-13 | 1996-11-19 | Baxter International Inc. | Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency |
| DE4337573C1 (de) * | 1993-11-04 | 1995-05-18 | Octapharma Ag | Verfahren zur Herstellung einer virusinaktivierten Faktor VIII enthaltenden Fraktion mittels chromatographischer Methoden |
| CA2276091A1 (en) * | 1996-12-27 | 1998-07-09 | Mochida Pharmaceutical Co., Ltd. | Cell membrane-directed drugs |
| PL203177B1 (pl) | 1999-02-22 | 2009-09-30 | Baxter Int | Sposób liofilizacji wodnego preparatu farmaceutycznego |
| US8110218B2 (en) * | 2000-11-30 | 2012-02-07 | The Research Foundation Of State University Of New York | Compositions and methods for less immunogenic protein-lipid complexes |
| US7351688B2 (en) * | 2003-02-05 | 2008-04-01 | The Research Foundation Of State University Of New York | Compositions and methods for less immunogenic protein formulations |
| US20050069578A1 (en) * | 2003-08-05 | 2005-03-31 | Balasubramanian Sathyamangalam V. | Reconstitution medium for protein and peptide formulations |
| CN101304757A (zh) * | 2005-06-29 | 2008-11-12 | 纽约州立大学研究基金会 | 免疫原性较低的蛋白质-脂质复合物的组合物和方法 |
| US8236518B2 (en) * | 2005-07-15 | 2012-08-07 | The University Of Vermont And State Agriculture College | Highly sensitive immunoassays and antibodies for detection of blood factor VIII |
| WO2007021822A2 (en) * | 2005-08-09 | 2007-02-22 | The Research Foundation Of State Of University Of New York At Buffalo | Compositions and methods of preparation of liposomal microparticulate il-12 |
| JP5160534B2 (ja) * | 2006-03-30 | 2013-03-13 | ザ リサーチ ファウンデイション オブ ステイト ユニバーシティー オブ ニューヨーク | 低免疫原性および長時間循環性タンパク質−脂質複合体の組成物 |
| US7875288B2 (en) * | 2006-03-30 | 2011-01-25 | The Research Foundation Of State University Of New York | Method for treating blood coagulation disorders |
| WO2008102469A1 (ja) * | 2007-02-23 | 2008-08-28 | Kwansei Gakuin Educational Foundation | 蛋白質結晶化剤および蛋白質結晶化剤を用いた蛋白質結晶化方法 |
| US20100168018A1 (en) | 2008-11-07 | 2010-07-01 | Baxter International Inc. | Factor viii formulations |
| CN103282045A (zh) * | 2010-12-16 | 2013-09-04 | 诺沃—诺迪斯克有限公司 | 因子viii水溶液 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4022758A (en) * | 1973-06-19 | 1977-05-10 | Ab Kabi | Isolation of coagulation factors I and VIII from biological material |
| DE3101752A1 (de) * | 1981-01-21 | 1982-08-26 | Behringwerke Ag, 3550 Marburg | "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen" |
| US4461833A (en) * | 1982-06-23 | 1984-07-24 | University Patents, Inc. | Chromatographically purifying proteolytic procoagulant enzyme from animal tissue extract |
| US4397841A (en) * | 1982-06-28 | 1983-08-09 | Monsanto Company | Production of blood coagulation factor VIII:C |
| US4508709A (en) * | 1983-12-05 | 1985-04-02 | Armour Pharmaceutical Company | Process for purifying factor VIII:C |
| GB8403473D0 (en) * | 1984-02-09 | 1984-03-14 | Special Trustees For St Thomas | Purification of factor viii |
| US4675385A (en) * | 1985-03-27 | 1987-06-23 | Alpha Therapeutic Corporation | Isolation of human plasma procoagulant protein factor VIII from biological factors |
-
1987
- 1987-07-16 US US07/074,123 patent/US4795806A/en not_active Expired - Lifetime
-
1988
- 1988-07-14 EP EP88111301A patent/EP0303064B1/en not_active Expired - Lifetime
- 1988-07-14 AT AT88111301T patent/ATE87632T1/de not_active IP Right Cessation
- 1988-07-14 ES ES88111301T patent/ES2053631T3/es not_active Expired - Lifetime
- 1988-07-14 DE DE8888111301T patent/DE3879803T2/de not_active Expired - Fee Related
-
1993
- 1993-04-01 GR GR930400557T patent/GR3007541T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0303064B1 (en) | 1993-03-31 |
| DE3879803T2 (de) | 1993-07-08 |
| EP0303064A3 (en) | 1990-05-16 |
| US4795806A (en) | 1989-01-03 |
| EP0303064A2 (en) | 1989-02-15 |
| DE3879803D1 (de) | 1993-05-06 |
| ES2053631T3 (es) | 1994-08-01 |
| ATE87632T1 (de) | 1993-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0303064A3 (en) | Phospholipid affinity purification of factor viii:c | |
| AU6733487A (en) | Mammalian interleukin-4 | |
| AU573523B2 (en) | Functional human urokinase proteins | |
| WO1991008298A3 (en) | Fusion proteins consisting of a ligand binding protein and a stable plasma protein | |
| EP1245678A3 (en) | Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome | |
| ES8403025A1 (es) | Procedimiento para preparar una solucion de insulina estabilizada. | |
| CA2097199A1 (en) | Preparation of prothrombin time reagents from recombinant human tissue factor and purified natural and synthetic phospholipids | |
| EP0344459A3 (en) | Expression of human serum albumin in metholotrophic yeasts | |
| ES8701780A1 (es) | Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo | |
| AU3473489A (en) | Expression of hepatisis b s and pres2proteins in methylotrophic yeasts | |
| AU3329989A (en) | Viper venom polypeptides and genetic expression | |
| EP0642507A4 (en) | Catalytic antibodies against cocaine and methods of using and producing same. | |
| AU5207196A (en) | Production of recombinant factor VIII in the presence of lipsome-like substances of mixed composition | |
| AU4043489A (en) | Improvements in or relating to reducing the strength of electro-magnetic fields | |
| WO1999019352A3 (en) | Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids | |
| AU1321988A (en) | The cloning of malaria-specific dna sequences: isolation of the gene for the 140 kd protein | |
| AU1294888A (en) | Recombinant alveolar surfactant protein | |
| SU1538846A1 (ru) | Лазерный материал |